These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6515702)
1. Binding of amantadine to red blood cells. Daugirdas JT; Ing IL; Cheng PJ; Wu MJ; Klawans HL; Soung LS Ther Drug Monit; 1984; 6(4):399-401. PubMed ID: 6515702 [No Abstract] [Full Text] [Related]
2. Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency. Ing TS; Mahurkar SD; Dunea G; Hayashi JA; Klawans HL; Markey WS Can Med Assoc J; 1976 Sep; 115(6):515. PubMed ID: 953934 [TBL] [Abstract][Full Text] [Related]
3. Amantadine toxicity in a patient with renal insufficiency. Armbruster KF; Rahn AC; Ing TS; Halper IS; Oyama JH; Klawans HL Nephron; 1974; 13(2):183-6. PubMed ID: 4850491 [No Abstract] [Full Text] [Related]
4. Plasma protein-binding of amantadine in maintenance hemodialysis patients. Ing TS; Cheng PJ; Wu MJ; Daugirdas JT; Soung LS Int J Artif Organs; 1984 Jul; 7(4):235. PubMed ID: 6490196 [No Abstract] [Full Text] [Related]
5. Plasma amantadine concentrations in patients with Parkinson's disease. Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501 [TBL] [Abstract][Full Text] [Related]
7. Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients. Müller T; Kuhn W; Quack G; Przuntek H J Neural Transm Suppl; 1995; 46():407-13. PubMed ID: 8821076 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism]. Völler GW; Deze J Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272 [No Abstract] [Full Text] [Related]
9. Amantadine-induced coma. Macchio GJ; Ito V; Sahgal V Arch Phys Med Rehabil; 1993 Oct; 74(10):1119-20. PubMed ID: 8215867 [TBL] [Abstract][Full Text] [Related]
10. Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Pacifici GM; Nardini M; Ferrari P; Latini R; Fieschi C; Morselli PL Br J Clin Pharmacol; 1976 Oct; 3(5):883-9. PubMed ID: 788761 [TBL] [Abstract][Full Text] [Related]
11. Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Miguel A; Miguel A; Linares M; Perez A; Moll R; Sanchis J; Escobedo JM; Miguel-Borja JM Nephron; 1988; 50(1):64-5. PubMed ID: 3173606 [No Abstract] [Full Text] [Related]
13. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism]. Man'kovskii NB; Vainshtok AB; Oleinik LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407 [No Abstract] [Full Text] [Related]
14. Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application. Yeh HH; Yang YH; Chen SH Electrophoresis; 2010 Jun; 31(11):1903-11. PubMed ID: 20446294 [TBL] [Abstract][Full Text] [Related]
16. Altered mental status in a transplant patient. Amantadine toxicity. Michalski LS; Hantsch Bardsley C; Holt DR; Milner JE; Hou SH Kidney Int; 2009 Jan; 75(2):243-4. PubMed ID: 19116645 [No Abstract] [Full Text] [Related]
17. [Intravenous and oral treatment with amantadine sulfate in Parkinson disease]. Brenner M; Haass A; Jacobi P; Schimrigk K Nervenarzt; 1988 Mar; 59(3):180-4. PubMed ID: 3374720 [TBL] [Abstract][Full Text] [Related]
18. [Heinz body formation and abnormal methemoglobin reduction. Expressions of damage to erythrocytes in chronic kidney failure]. Grieger M; Rapoport S Haematologia (Budap); 1976; 10(2):157-68. PubMed ID: 1030681 [TBL] [Abstract][Full Text] [Related]